Natural History of Biochemical Progression After Radical Prostatectomy Based on Length of a Positive Margin

Urology

Volumn 71, Issue 2, 2008, Pages 308-312

  Ochiai, Atsushi ^a   Sotelo, Tiffany ^a   Troncoso, Patricia ^a   Bhadkamkar, Viju ^a   Babaian, R Joseph ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; SEMINAL VESICLE; TREATMENT DURATION;

AGED; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 39549112270     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.08.042     Document Type: Article

References (19)

1. Ohori M., Wheeler T.M., Kattan M.W., et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 154 (1995) 1818-1824
2. Hull W., Rabbani F., Abbas F., et al. Cancer control with radical prostatectomy alone in 1000 consecutive patients. J Urol 167 (2002) 528-534
3. Epstein J.I., Pizov G., and Walsh P.C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71 (1993) 3582-3593
4. Chang L., Darson M.F., Bergstralh E.J., et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer 86 (1999) 1775-1782
5. Epstein J.I., Partin A., Sauvageot J., et al. Prediction of progression following radical prostatectomy: a multivariate analysis of 721 men with long-term follow up. Am J Surg Pathol 20 (1996) 286-292
6. Sakr W.A., Wheeler T.M., Blute M., et al. Staging and reporting of prostate cancer-sampling of the radical prostatectomy specimen. Cancer 78 (1996) 366-368
7. Watson R.B., Civantos F., and Soloway M.S. Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. Urology 48 (1996) 80-90
8. Sofer M., Hamilton-Nelson K.L., Civantos F., et al. Positive surgical margins after radical retropubic prostatectomy: the influence of site and number on progression. J Urol 167 (2002) 2453-2456
9. Babaian R.J., Troncoso P., Bhadkamkar V.A., et al. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer 91 (2001) 1414-1422
10. Ayala A.G., Ro J.Y., Babaian R., et al. The prostatic capsule: does it exist?. Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 13 (1989) 21-27
11. Babaian R.J., Troncoso P., Steelhammer L.C., et al. Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability. J Urol 154 (1995) 1808-1812
12. Gleason D.F. Histologic grading and clinical staging of carcinoma of the prostate. In: Tannenbaum M. (Ed). Urologic Pathology: The Prostate (1977), Lea & Febiger, Philadelphia 171-197
13. Chen M.E., Johnson D., Reyes A.O., et al. A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol 27 (2003) 1291-1301
14. Stamey T.A., Villers A.A., McNeal J.E., et al. Positive surgical margins at radical prostatectomy: importance of the apical dissection. J Urol 143 (1990) 1166-1172
15. Eastham J.A., Kattan M.W., Riedel E., et al. Variation among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 170 (2003) 2292-2295
16. Freedland S.J., Aronson W.J., Presti J.R.J.C., et al. The Search Database Study Group: Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3?. Results from the search database. J Urol 169 (2003) 2142-2146
17. Catalona W.J., and Smith D.S. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 152 (1994) 1837-1842
18. Mian B.M., Troncoso P., Okihara K., et al. Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol 167 (2002) 1675-1680
19. D'Amico A.V., Whittington R., Malkowicz S.B., et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radial prostatectomy for prostate cancer. J Urol 154 (1995) 131-138